The present disclosure relates generally to dispensers for dispensing fluids or other substances and, more particularly, to a dispenser having a rigid vial, a flexible bladder disposed within the rigid vial and defining a chamber between the flexible bladder and rigid vial for receiving therein a fluid or other substance, and a nozzle and pump assembly coupled in fluid communication with chamber for dispensing fluids or other substances therefrom.
Typical fluid dispensers include a container defining therein a chamber for receiving a fluid to be dispensed, a nozzle and pump assembly mounted on the container, and a dip tube extending downwardly from the nozzle into the chamber for pumping the fluid from the bottom of the chamber, through the dip tube, and out of the dispenser. Other known dispensers include a vial and a flexible bladder received within the vial. For example, U.S. Pat. No. 6,062,430 to Fuchs shows in FIG. 1 a dispensing container with variable volume compensation including a bottle-shaped vessel 2 in the form of a thin-walled, hollow body made from soft elastic plastic, and a reception container 15 formed of a wrinkle film encapsulated within the vessel body 2.
One of the drawbacks associated with typical prior art fluid dispensers is that the fluid chamber(s) are not maintained in a substantially airless condition throughout the storage, shelf life and/or usage of the dispenser. For example, the nozzles and/or valves used in typical prior art dispensers frequently are incapable of maintaining the dispenser in a hermetically sealed condition. Such nozzles and/or valves allow the passage of air or other gases therethrough and into contact with the medicament or other substance contained within the fluid chamber(s). In addition, such nozzles and/or valves frequently allow vapor loss therethrough either during the storage, shelf life or usage of the dispensers.
Another drawback associated with prior art dispensers is that the materials of construction may undergo creep that, in turn, causes seals formed within the dispensers to leak. Many medicaments are maintained in storage and/or on store shelves for at least several, and in some instances, many months. During transportation and storage, the dispensers can be subjected to varying atmospheric conditions involving large variations in atmospheric temperature, pressure and/or humidity. As a result, the dispensers are frequently subjected to substantial differential thermal expansion and/or contraction that, in turn, cause the materials of construction to undergo creep. The seals and other components of such prior art dispensers typically are not designed to address such creep, and as a result, the dispensers develop leaks or otherwise allow air ingress and/or vapor loss when subjected to such long periods of storage or varying atmospheric conditions. For example, some polyethylene dispensers have been known to lose between about 10% to 25% of the weight of their contents during storage. Such weight loss is believed to be due to vapor loss from the medicament or other fluid-containing chambers through the polyethylene walls of the dispensers and/or through leaks otherwise created in the seals or other structural interfaces of the containers. The vapor loss is typically offset by air ingress into the chambers. Vapor loss and/or air ingress is particularly problematic for dispensers containing medicaments, such as pharmaceutical preparations or vaccines, because they tend to dilute each predetermined dosage of the medicament dispensed from the container, and/or cause the dispenser to dispense inconsistent concentrations of medicament from one dose to the next.
Yet another disadvantage associated with prior art dispensers is that because they cannot reliably maintain the medicament or other substance contained therein in an airtight condition, they cannot be used for either multiple dose applications or preservative-free formulations. The use of single dose dispensers can be substantially more expensive than multiple dose dispensers. In addition, the preservatives used in many medicaments, such as pharmaceutical preparations and vaccines, can cause adverse reactions in patients and/or dilute the effect of the medicament on the patient.
Another drawback of prior art dispensers is that the ullage or “dead space” inherent in such dispensers allows sediment build-up. Many medicaments and other formulations contained within such dispensers are suspensions. The ullage or dead space in the prior art dispensers allows the solutes or other solid components of such suspensions to form sediment therein. Such settling of the suspensions dilutes the medicaments or other substances contained within the dispensers and, in turn, alters the medicament and/or the concentration of medicament in each patient dose.
Another drawback associated with many prior art dispensers is that they can only dispense the medicament or other substance contained therein in an upright or other single orientation. This drawback prevents such dispensers from being used effectively in other orientations, such as upside down. In addition, because such dispensers do not maintain the medicament or other substance contained therein in an airless condition, they cannot be used in low gravity environments, such as outer space.
Accordingly, it is an object of the present invention to overcome one or more of the above-described drawbacks and disadvantages of the prior art.
In accordance with a first aspect, the present invention is directed to a dispenser for dispensing a fluid. The dispenser comprises a rigid housing, and a flexible bladder mounted within the housing and defining an interior chamber within the flexible bladder, and a fluid-receiving chamber between the flexible bladder and the rigid housing. The dispenser further comprises means for creating a first pressure within the fluid-receiving chamber greater than a second pressure within the interior chamber of the bladder to thereby prevent the ingress of gases or vapors into the fluid-receiving chamber. In a currently preferred embodiment of the present invention, the means for creating the pressure differential is formed by a resilient material of the bladder that flexes the bladder outwardly toward an expanded condition, and thereby creates the first pressure within the fluid-receiving chamber greater than the second pressure in the interior chamber of the bladder. Preferably, the resilient bladder is molded in the expanded condition, and therefore the resilient bladder will inherently tend to force itself into the expanded condition and thereby create the desired pressure differential between the fluid-receiving chamber and the interior chamber of the bladder.
A currently preferred embodiment of the dispenser further comprises a pump coupled in fluid communication with the fluid-receiving chamber for pumping a fluid received therein from the dispenser; and a one-way valve coupled in fluid communication with the pump for allowing the passage of the pumped fluid therethrough and preventing the passage of fluids in the opposite direction. The one-way valve is preferably formed by a nozzle, and a flexible cover overlying the nozzle and creating the one-way valve at the interface of the nozzle and cover.
Also in accordance with a preferred embodiment of the present invention, the dispenser further comprises a seal formed between the flexible bladder and the rigid vial for sealing the fluid-receiving chamber. The seal includes a first protuberance extending radially outwardly on an outer surface of the flexible bladder, and a second protuberance axially spaced relative to the first protuberance and extending radially inwardly on an inner surface of the bladder. The first and second protuberances are subject to radial compression to seal the interface between the flexible bladder and rigid vial. Preferably, the first protuberance extends about an outer peripheral surface of the bladder and defines an outer annular sealing surface, and the second protuberance extends about an inner peripheral surface of the bladder and defines an inner annular sealing surface. In addition, the first protuberance defines a tapered surface for directing bladder material in approximately the direction of the second protuberance to thereby facilitate maintaining a fluid-tight seal in the event of bladder material creep. The seal preferably further includes a peripheral flange extending about an open end of the flexible bladder and subject to axial compression for further sealing the interface between the bladder and rigid vial.
Also in accordance with a preferred embodiment of the present invention, the dispenser further comprises a plug receivable within an open end of the rigid vial and engageable with at least one of the first and second protuberances for radially compressing the protuberances to seal the interface between the flexible bladder and rigid vial. The plug defines at least one aperture therethrough in fluid communication with the interior chamber of the flexible bladder. Preferably, a two-way valve of the dispenser is coupled in fluid communication between the interior chamber of the flexible bladder and the aperture of the plug for preventing fluid communication between the interior chamber of the bladder and the ambient atmosphere when a pressure differential across the two-way valve is less than a threshold level. The two-way valve preferably is formed by a flexible, annular protuberance extending radially inwardly from an inner peripheral surface of the flexible bladder, and engageable with an annular surface of the plug to thereby seal the interface between the flexible bladder and plug. In a currently preferred embodiment of the present invention, the annular protuberance defines axially-opposed surfaces that taper inwardly in the radial direction to facilitate flexing of the protuberance in response to the pressure differential across the protuberance exceeding the predetermined threshold level.
The flexible bladder of the dispenser further defines an open end and a closed end, and is movable between a collapsed condition and an expanded condition. Upon expansion of the flexible bladder from the collapsed condition into the expanded condition, the flexible bladder and rigid vial define an annular gap therebetween. In a currently preferred embodiment, the annular gap defines an increasing width in the axial direction from the open end toward the closed end of the flexible bladder, to facilitate removal of fluid from the fluid-receiving chamber upon expansion of the bladder. Preferably, the flexible bladder initially contacts the rigid vial adjacent to or near the open end of the bladder, and then progressively engages the rigid vial in the axial direction from the open end toward the closed end of the flexible bladder with further expansion thereof. Also in accordance with a preferred embodiment of the dispenser, the flexible bladder defines an external morphology in an expanded condition, the rigid vial defines an internal morphology, and the external and internal morphologies are substantially the same to thereby allow the flexible bladder to conformably contact the rigid vial and substantially eliminate any dead space in the fluid-receiving chamber therebetween.
In accordance with a preferred embodiment of the present invention, the pump of the dispenser comprises a piston, and a slide for slidably receiving the piston therein. At least one of the piston and the slide is reciprocable relative to the other. In addition, the piston is made of a relatively hard material, the slide is made of a relatively soft material, and the piston causes a compression zone of the slide to flex outwardly upon moving at least one of the piston and the slide relative to the other to thereby effect a fluid-tight seal between the piston and slide. In addition, forming the slide from a relatively flexible material allows the slide to be formed integral with a nozzle, such as by molding the two components in a single part, wherein the integral nozzle and slide may be released from a core pin by injecting pressured air therebetween.
Also in accordance with a preferred embodiment of the present invention, the dispenser preferably further comprises means for controlling the flexible bladder to collapse into a predetermined collapsed condition. In one embodiment of the present invention, the means for controlling includes a plurality of legs extending axially inwardly into the interior chamber of the flexible bladder for conformably contacting the flexible bladder upon collapse thereof. In another embodiment of the present invention, the means for controlling is defined by at least one axially elongated surface discontinuity formed in the flexible bladder.
In accordance with another aspect of the present invention, the dispenser includes a needle penetrable and laser resealable member that is capable of being penetrated by a needle or like injection member for introducing a predetermined substance into the fluid-receiving chamber. In one such embodiment, the flexible bladder includes a first portion substantially infusible in response to the application of thermal energy thereto and compatible with the substance to be received within the fluid-receiving chamber, and a second portion overlying the first portion and fusible in response to the application of thermal energy thereto. Thus, the second portion enables the formation of a substantially fluid-tight seal between the flexible bladder and fluid-receiving chamber in a region thereof penetrated by the needle or like injection member. In one embodiment of the present invention, the second portion is formed of either a thermoplastic or an elastomeric material, and the bladder, including the first portion thereof, is formed of vulcanized rubber.
One advantage of the currently preferred embodiments of the dispenser is that the pressure differential between the fluid-receiving chamber and the internal chamber of the bladder and ambient atmosphere substantially prevents the ingress of air or other gases or vapors through the flexible bladder, or otherwise into the fluid-receiving chamber. As a result, the dispensers of the present invention may maintain the medicaments or other substances contained therein in an airless condition throughout substantial periods of storage, shelf life and/or use. Accordingly, the dispensers of the present invention are particularly well suited for dispensing multiple doses of non-preserved medicaments or other substances requiring storage in an airless condition.
Another advantage of the currently preferred embodiments of the dispensers is that the seal formed between the flexible bladder and the rigid vial radially and axially directs the material of the flexible bladder to persistently maintain a fluid-tight seal regardless of any creep of the material during the storage or shelf-life of the dispenser. In addition, the one-way valve employed in the preferred embodiments of the present invention further maintains the fluid-receiving chamber in a hermetically-sealed condition throughout the storage, shelf-life and/or use of the dispenser.
Yet another advantage of the currently preferred embodiments of the dispensers is that because the medicament or other substance is maintained in an airless condition in the fluid-receiving chamber, the dispensers may be used in virtually any orientation, and furthermore, may be used in low gravity environments.
Another advantage of the dispensers of the present invention is that the flexible bladder preferably defines an external morphology substantially matching the internal morphology of the rigid vial. As a result, the flexible bladder may expand and conformably contact the rigid vial throughout the interface between these two parts and, in turn, eliminate any dead space within the fluid-receiving chamber.
Yet another advantage of the currently preferred embodiments of the dispensers is that the two-way valve coupled in fluid communication between the interior chamber of the flexible bladder and the ambient atmosphere prevents any exchange of gases or vapors between the interior chamber of the bladder and ambient atmosphere, provided the pressure differential across the valve is less than a predetermined level. As a result, the two-way valve creates a relatively stable micro-atmosphere within the interior chamber of the flexible bladder, thus insulating the interior chamber from fluctuations in pressure and/or humidity in the ambient atmosphere and thereby further preventing the ingress of gas or vapors into the fluid-receiving chamber.
Other objects and advantages of the present invention and/or the currently preferred embodiments thereof will become apparent in view of the following detailed description and accompanying drawings.
In
In use, the eye cover 16 is placed adjacent to the tissue surrounding the eye with the eyelid depressor 36 engaging the tissue adjacent to the ocular cul-de-sac. Upon squeezing the trigger 18, the eyelid depressor 36 rotates in the direction of the arrow 41, and in turn moves the tissue adjacent to the eye to expose the ocular cul-de-sac. Rotation of the eyelid depressor 36 is caused by the wheel 27 which also uncovers a nozzle 42 formed at the adjacent end of the dispenser 10. Simultaneously, the spring arm 30 forces the rim 34 of the dispenser 10 away from the fixed nozzle 42 to thereby prime the pump of the dispenser, as described in further detail below. Upon squeezing the trigger 18 and correspondingly extending the dispenser 10 within the housing 12, the free end 32 of the spring arm 30 eventually disengages itself from the rim 34 of the dispenser to thereby release the extended dispenser from the spring arm. As a result, due to the resiliency or spring-like nature of the nozzle 42, as described further below, the extended dispenser contracts or moves back toward the nozzle and, in turn, releases a predetermined dosage of medicament (or other substance) from the nozzle and into the ocular cul-de-sac of the user's eye. Then, when the user removes the ocular treatment apparatus 8 from his or her eye and releases the trigger 18, the spring arm 30 automatically returns to its original or resting position as shown in
Other examples of ocular treatment apparatus that may employ the dispenser 10 are described in U.S. Pat. Nos. 4,981,479 and 6,033,384, which are assigned to the assignee of the present invention and are hereby incorporated by reference as part of the present disclosure. Accordingly, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the dispensers of the present invention may be utilized in any of numerous different apparatus or systems to facilitate holding and dispensing medicaments or other fluids, liquids or other substances contained therein, such as nasal inhalers.
Referring now to
Referring now also to
As shown best in
As shown in
Referring now to
As shown in
As illustrated in
With reference to
The bellows portion 148 extends between the mounting portion 140 and nozzle cover 150, and comprises a plurality serpentine or inversely curled portions 152 which function to provide resiliency in a direction generally parallel to a central axis 154 and sufficient spring-like force to either drive the piston or the nozzle away from the other and return the piston to the top of its stroke upon dispensing a predetermined dose of a medicament or other substance contained within the chamber 55. Referring also to
In operation, as described above in connection with
One advantage of the pump configuration of the illustrated embodiment, and as indicated by the arrow indicating the path of fluid flow in
Yet another advantage of the illustrated pump configuration is that the bellows 148 is sealed relative to the variable-stroke volume 113 to thereby prevent any of the medicament or other substance contained within the chamber 55 from collecting in the space between the bellows and the piston or slide. As can be seen, the o-ring or like seal 90 forms a fluid-tight seal between the piston and the slide, thus preventing any fluid from flowing therethrough and into the bellows. Similarly, fluid-tight seals are formed at the interfaces of the cover 62, nozzle 58 and slide 60, including fluid-tight seals at the interfaces of the slide engagement portion 158 of the cover and the slide 60, and at the interface of the annular rib 126 of the cover and at the annular groove 122 of the nozzle 58.
Referring now to
As shown in
Referring now to
In the currently preferred embodiments, the flexible bladder 54 is made of a resilient material as described above and is molded in the expanded condition. Accordingly, when collapsed in the manner described further below, the resilient bladder tends to force itself outwardly and, in turn, increase the pressure of the medicament or other fluid in the main fluid chamber 55 in comparison to the pressure in the interior of the bladder. A significant advantage of this pressure differential is that it facilitates in preventing the ingress of air, other gases or vapors located within the interior chamber of the bladder through the bladder or otherwise into the main fluid chamber. As a result, the dispensers of the present disclosure are particularly well suited for containing multiple dose, non-preserved medicaments or other substances, and in maintaining such substances in a sterile, airless condition, throughout substantial periods of storage, shelf life and/or use of the dispensers. This advantageous feature also facilitates in preventing any changes in the ambient conditions of the dispenser from affecting the airless condition of the main fluid chamber 55, and otherwise prevents the ingress of air, other gases or vapors into the main fluid chamber.
The flexible bladder 54 preferably also provides a barrier to the passage of gas, such as air, through the flexible bladder, and thus may be composed of a single layer of material that has a substantially reduced permeability to air. In one embodiment, the bladder 54 is composed of a multi-layered material. For example, as illustrated in
Referring now again to
As shown in
As illustrated in
During storage and/or shelf life of the dispenser 10, the material of the flexible bladder 54 may flow or move in order to equalize the tensile and compressive forces that it is subject to. Creep, as used herein, refers to a change in property of the material wherein there is a loss in resilience and memory of the material. In particular, after undergoing creep the elastic material may permanently deform and lose at least some of its original elasticity. Accordingly, after assembly and during filling of the dispenser 10, the cavity 180 of the flexible bladder 54 may be subject to low pressure which causes collapse and elastic deformation thereof which is maintained by the pressure of fluid filled in the main fluid chamber 55 (
As shown in
As shown in
Referring now to
It will be understood that both the discontinuities 206 and 206′ function to allow for a reduction in length of the portions of the wall 208′ necessary to collapse the flexible bladders 54 and 54′. While this function is being described in connection with the embodiment of
As illustrated in
Returning to
In
Referring now to
The filling of the dispenser 10 is illustrated schematically in
As shown in
In
As shown in
As described above, the flexible bladder 538 is preferably made of a relatively low permeability elastomer, such as a vulcanized butyl rubber, or other rubbers. Such rubbers have demonstrated proven stability and/or compatibility with a wide variety of medicaments, such as pharmaceutical preparations and vaccines, and other substances, and therefore are currently preferred for such applications. In the currently preferred embodiment, the flexible bladder 354 is molded in its expanded condition, and when collapsed, the resilient nature of the bladder tends to force the bladder outwardly toward its expanded condition. The resilient forces within the bladder apply a pressure against the fluid within the main fluid chamber 355, and therefore create a higher pressure in the main fluid chamber 355 in comparison to that of the interior chamber 480 of the bladder. As a result, the pressure differential prevents the ingress of air or other gases or vapors through either the flexible bladder or rigid vial, or otherwise into the main fluid chamber. Thus, the material and/or configuration of the bladder are preferably selected to maintain a pressure differential sufficient to prevent the ingress of air or other gases or vapors into the main fluid chamber under a variety of atmospheric conditions. As described above, the preferred rubber materials disclosed herein for constructing the flexible bladder are exemplary, and numerous other materials that are currently, or later become known for performing the function of the flexible bladder may be equally employed.
As shown in
As shown typically in
As shown in
As shown in
Forming the integral nozzle and slide of a relatively soft and/or flexible material allows the compression zone 436 of the slide to flex outwardly in order to remove the part from a core pin upon molding the part, and thus enables the nozzle and slide to be integrally molded as a single part. Preferably, compressed air is injected between the core pin and interior surface 392 of the slide to facilitate removal of the part from the core pin (not shown).
As shown in
As shown typically in
As shown in
Turning to
As shown in
The resealable member 844 is preferably made of a resilient polymeric material, such as a blend of the polymeric material sold by GLS under the registered trademark KRATON® and a low-density polyethylene, such as the polyethylene sold by Dow Chemical Co. under the trademarks ENGAGE™ or EXACT™. An important feature of the resealable member 844 is that it be resealable to form a gas-tight seal after inserting a needle, syringe or like injection member through the resealable member. Preferably, the resealable member can be sealed by heating the area punctured by the needle in a manner known to those skilled in the pertinent art and described in the above-mentioned co-pending patent application. One advantage of the blended polymer described above is that it is known to minimize the degree to which the medicament or other substance can be absorbed into the polymer in comparison to KRATON® itself.
As shown in
The laser or other energy source includes a laser or other suitable radiation source optically coupled to a scanning mirror. The laser includes a commercially available CO2 or YAG laser. The CO2 laser operates at a wavelength of approximately 10.6 μm. At this wavelength, absorption of the laser energy is governed by the electrical conductivity of the material. Therefore, an insulating material, such as the elastomeric material of the resealable member 844, absorbs and converts most of the incident energy into thermal energy to cauterize the receiving surface. The YAG laser operates at wavelength of approximately 1.06 μm. At this frequency, absorption is governed by the lattice atoms. Thus, a clear or transparent polymer with little ionization would be permeable to the laser beam. Accordingly, when employing a YAG laser, it is desirable to add a colorant to the elastomeric material of the resealable member in a manner known to those of ordinary skill in the pertinent art in order to enhance its absorption of the laser energy. A significant advantage of the YAG laser is that the superficial layer of the penetrable region of the resealable member, and any germs, bacteria or other contaminants thereon, are transformed into plasma to rapidly and thoroughly sterilize the effected surface. If necessary, a UV-filtration coating may be applied to the surfaces of the enclosure for the apparatus of the invention to prevent the operators from receiving any unnecessary UV exposure.
The present inventor has demonstrated that beam energies in the range of approximately 15 to 30 W are sufficient to effectively cauterize the surface of the elastomeric resealable member. In addition, bio-burden testing has demonstrated that laser energies of approximately 20 W or greater may achieve a 6.0 log reduction. At these energies, the apparatus of the present invention may effectively sterilize the surface within a cycle time of approximately 0.5 seconds. Accordingly, a significant advantage of the laser cauterization apparatus and method of the present invention is that they may involve significantly shorter cycle times than various direct heat methods. Yet another advantage of the laser cauterization of the present invention, is that it involves both a non-contact method and apparatus, and therefore there is no need to be concerned with the cleaning of a contact head or like heating surface.
After filling the dispenser with the medicament or other formulation and withdrawing the needle 848 from the resealable member 844, the penetrated region of the resealable member defines a needle hole along the path of the withdrawn needle. Upon withdrawing the needle 848, the vulcanized rubber base of the bladder is sufficiently resilient to close upon itself in the penetrated region and thereby maintain the dispenser in a sealed condition. However, vapors, gases and/or liquid may be allowed over time to pass through the needle hole, and therefore each dispenser is passed through a sealing station to heat seal the resealable portion promptly after withdrawing the needle therefrom. As indicated above, the laser source and scanning mirror are employed to heat seal the penetrated region of the resealable member. Accordingly, the same type of laser source and scanning mirror as described above may be employed in the heat sealing station to perform this function, or alternatively, a different type of laser system may be employed. In a currently preferred embodiment of the present invention, a CO2 laser of approximately 50 W is employed to seal a region approximately 0.10 inch in diameter in the resealable member.
One advantage of the illustrated dispenser is that the underlying rubber base of the resealable member thermally insulates the heated region from the medicament in the dispenser to thereby maintain the medicament in the dispenser within an appropriate temperature range throughout the cauterization and heat sealing processes and thereby avoid any thermal damage to the medicament.
As may be recognized by those skilled in the pertinent art based on the teachings herein, numerous changes and modifications may be made to the above-described and other embodiments of the present invention, without departing from its scope as defined in the appended claims. Accordingly, this detailed description of preferred embodiments is to be taken in an illustrative, as opposed to a limiting sense.
This patent application is a continuation of U.S. patent application Ser. No. 11/351,716, filed Feb. 10, 2006, now U.S. Pat. No. 8,240,521, entitled “Fluid Dispenser Having a One-Way Valve, Pump, Variable-Volume Storage Chamber, and a Needle Penetrable and Laser Resealable Portion, which is a continuation of U.S. patent application Ser. No. 10/890,465, filed Jul. 12, 2004, now U.S. Pat. No. 7,000,806, entitled “Fluid Dispenser Having a One Way Valve, Pump, Variable-Volume Storage Chamber, and a Needle Penetrable and Laser Resealable Portion”, which is a continuation of U.S. patent application Ser. No. 10/001,745, filed Oct. 23, 2001, now U.S. Pat. No. 6,761,286, entitled “Fluid Dispenser Having a Housing and Flexible Inner Bladder”, which claims the benefit of U.S. Provisional Application No. 60/242,595, filed Oct. 23, 2000, entitled “Fluid Dispenser Having A Rigid Vial And Flexible Inner Bladder”, and U.S. Provisional Application No. 60/242,974, filed Oct. 24, 2000, entitled “Fluid Dispenser Having A Rigid Vial And Flexible Inner Bladder”, all of which are hereby incorporated by reference as part of the present disclosure.
Number | Name | Date | Kind |
---|---|---|---|
1392600 | Rose | Oct 1921 | A |
1471091 | Bessesen | Oct 1923 | A |
1641534 | Davis | Sep 1927 | A |
1854458 | De Quincy et al. | Apr 1932 | A |
2014881 | Carlstrom | Sep 1935 | A |
2246693 | Ohme | Jun 1941 | A |
2317270 | Harris | Apr 1943 | A |
2471852 | Bau | May 1949 | A |
2503147 | Applezweig | Apr 1950 | A |
2649995 | Muskin | Aug 1953 | A |
2667986 | Perelson | Feb 1954 | A |
2715980 | Frick | Aug 1955 | A |
2740556 | Baron | Apr 1956 | A |
2751119 | Manning, Sr. | Jun 1956 | A |
2844285 | Moran | Jul 1958 | A |
RE24918 | Mills | Jan 1961 | E |
3055367 | Thorstad | Sep 1962 | A |
3092278 | Järnhäll | Jun 1963 | A |
3136440 | Krug et al. | Jun 1964 | A |
3160329 | Radic et al. | Dec 1964 | A |
3166096 | Lang | Jan 1965 | A |
3173579 | Curie et al. | Mar 1965 | A |
3180374 | Muller | Apr 1965 | A |
3193128 | Ravn | Jul 1965 | A |
3211340 | Zander | Oct 1965 | A |
3220611 | Zander | Nov 1965 | A |
3231149 | Yuza | Jan 1966 | A |
3278063 | Kranzhoff | Oct 1966 | A |
3340671 | Loo | Sep 1967 | A |
3343422 | McSmith | Sep 1967 | A |
3392859 | Fischer | Jul 1968 | A |
3416425 | Rigolini | Dec 1968 | A |
3424329 | Hersherg et al. | Jan 1969 | A |
3499582 | Berney | Mar 1970 | A |
3507568 | Gordeev | Apr 1970 | A |
3554399 | Chapman et al. | Jan 1971 | A |
3561644 | Works et al. | Feb 1971 | A |
3677444 | Merrill | Jul 1972 | A |
3685248 | Godelaine | Aug 1972 | A |
3698595 | Gortz et al. | Oct 1972 | A |
3729032 | Tischlinger et al. | Apr 1973 | A |
3811591 | Novitch | May 1974 | A |
3820689 | Cocita | Jun 1974 | A |
3921333 | Clendinning et al. | Nov 1975 | A |
3987938 | Cooprider et al. | Oct 1976 | A |
3993069 | Buckles et al. | Nov 1976 | A |
4015752 | Meuresch et al. | Apr 1977 | A |
4023607 | Jensen et al. | May 1977 | A |
4048255 | Hillier et al. | Sep 1977 | A |
4078705 | Butcher | Mar 1978 | A |
4099651 | Von Winckelmann | Jul 1978 | A |
4132334 | Danks | Jan 1979 | A |
4168020 | Benson | Sep 1979 | A |
4216236 | Mueller et al. | Aug 1980 | A |
4233262 | Curto | Nov 1980 | A |
4239132 | Mueller et al. | Dec 1980 | A |
4240465 | Rader | Dec 1980 | A |
4249675 | Nilson | Feb 1981 | A |
4250611 | Wong | Feb 1981 | A |
4256242 | Christine | Mar 1981 | A |
4264018 | Warren | Apr 1981 | A |
4314654 | Gaubert | Feb 1982 | A |
4346708 | LeVeen et al. | Aug 1982 | A |
4349133 | Christine | Sep 1982 | A |
4366912 | Matakura et al. | Jan 1983 | A |
4390111 | Robbins et al. | Jun 1983 | A |
4401239 | Thomassen | Aug 1983 | A |
4416395 | Gaubert | Nov 1983 | A |
4420100 | Mueller | Dec 1983 | A |
4425366 | Sozzie et al. | Jan 1984 | A |
4425698 | Petrie | Jan 1984 | A |
4440316 | Christine | Apr 1984 | A |
4441538 | Larkin | Apr 1984 | A |
4444330 | Kasai et al. | Apr 1984 | A |
4457454 | Meshberg | Jul 1984 | A |
4479989 | Mahal | Oct 1984 | A |
4482585 | Ohodaira et al. | Nov 1984 | A |
4493438 | Rutter | Jan 1985 | A |
4499148 | Goodale et al. | Feb 1985 | A |
4501781 | Kushida et al. | Feb 1985 | A |
4516691 | Christine et al. | May 1985 | A |
4520948 | Hampel et al. | Jun 1985 | A |
4526294 | Hirschmann et al. | Jul 1985 | A |
4547900 | Larkin | Oct 1985 | A |
4561571 | Chen | Dec 1985 | A |
4578295 | Jabarin | Mar 1986 | A |
4579757 | Su et al. | Apr 1986 | A |
4602725 | Malpas et al. | Jul 1986 | A |
4603066 | Jabarin | Jul 1986 | A |
4603793 | Stern | Aug 1986 | A |
4607764 | Christine | Aug 1986 | A |
4636412 | Field | Jan 1987 | A |
4660737 | Green et al. | Apr 1987 | A |
4664275 | Kasai et al. | May 1987 | A |
4667854 | McDermott et al. | May 1987 | A |
4682703 | Kasai et al. | Jul 1987 | A |
4700838 | Falciani et al. | Oct 1987 | A |
4703781 | Meyer et al. | Nov 1987 | A |
4704510 | Matsui | Nov 1987 | A |
4722459 | Goncalves | Feb 1988 | A |
4747834 | Prindle | May 1988 | A |
4760937 | Evezich | Aug 1988 | A |
4776495 | Vignot | Oct 1988 | A |
4784652 | Wikstrom | Nov 1988 | A |
4795063 | Sekiguchi et al. | Jan 1989 | A |
4815619 | Turner et al. | Mar 1989 | A |
4817830 | Yavorsky | Apr 1989 | A |
4823990 | Roggenburg et al. | Apr 1989 | A |
4830229 | Ball | May 1989 | A |
4834152 | Howson et al. | May 1989 | A |
4842028 | Kaufman et al. | Jun 1989 | A |
4854481 | Bohl et al. | Aug 1989 | A |
4854483 | Haggart | Aug 1989 | A |
4859513 | Gibbons et al. | Aug 1989 | A |
4880675 | Mehta | Nov 1989 | A |
4910147 | Bacehowski et al. | Mar 1990 | A |
4910435 | Wakalopulos | Mar 1990 | A |
4921733 | Gibbons et al. | May 1990 | A |
4964540 | Katz | Oct 1990 | A |
4981479 | Py | Jan 1991 | A |
5009654 | Minshall et al. | Apr 1991 | A |
5031675 | Lindgren | Jul 1991 | A |
5033647 | Smith et al. | Jul 1991 | A |
5038839 | Morimoto et al. | Aug 1991 | A |
5074440 | Clements et al. | Dec 1991 | A |
5085332 | Gettig et al. | Feb 1992 | A |
5088612 | Storar et al. | Feb 1992 | A |
5088995 | Packard et al. | Feb 1992 | A |
5099885 | Nilsson | Mar 1992 | A |
5100027 | Gueret | Mar 1992 | A |
5102705 | Yammoto et al. | Apr 1992 | A |
5108007 | Smith et al. | Apr 1992 | A |
5129212 | Duffey et al. | Jul 1992 | A |
5145083 | Takahashi | Sep 1992 | A |
5154319 | Deininger et al. | Oct 1992 | A |
5176510 | Nilsson | Jan 1993 | A |
5178300 | Haviv et al. | Jan 1993 | A |
5226568 | Newton et al. | Jul 1993 | A |
5238150 | Williams | Aug 1993 | A |
5238153 | Castillo et al. | Aug 1993 | A |
5263946 | Klug | Nov 1993 | A |
5267986 | Py | Dec 1993 | A |
5271513 | Crosnier et al. | Dec 1993 | A |
5303851 | Libit et al. | Apr 1994 | A |
5320845 | Py | Jun 1994 | A |
5332121 | Schmidt et al. | Jul 1994 | A |
5337775 | Lane et al. | Aug 1994 | A |
5339972 | Crosnier et al. | Aug 1994 | A |
5341854 | Zezulka et al. | Aug 1994 | A |
5360145 | Gueret | Nov 1994 | A |
5366108 | Darling | Nov 1994 | A |
5390469 | Shimizu et al. | Feb 1995 | A |
5401259 | Py | Mar 1995 | A |
5409146 | Hazard et al. | Apr 1995 | A |
5411065 | Meador et al. | May 1995 | A |
5414267 | Wakalopulos | May 1995 | A |
5419465 | Schroeder | May 1995 | A |
5429254 | Christine | Jul 1995 | A |
5435463 | Hodgson | Jul 1995 | A |
5452826 | Stern | Sep 1995 | A |
5453096 | Lataix | Sep 1995 | A |
5454488 | Geier | Oct 1995 | A |
5464125 | Daansen | Nov 1995 | A |
5484566 | Gabbard | Jan 1996 | A |
5492252 | Gueret | Feb 1996 | A |
RE35187 | Gortz | Mar 1996 | E |
5496302 | Minshall et al. | Mar 1996 | A |
5499758 | McCann et al. | Mar 1996 | A |
RE35203 | Wakalopulos | Apr 1996 | E |
D368774 | Py | Apr 1996 | S |
5505341 | Gueret | Apr 1996 | A |
5514339 | Leopardi et al. | May 1996 | A |
5549141 | Meador et al. | Aug 1996 | A |
D374719 | Py | Oct 1996 | S |
5562960 | Sugiura et al. | Oct 1996 | A |
5565160 | Makuuchi et al. | Oct 1996 | A |
5612588 | Wakalopulos | Mar 1997 | A |
5613517 | Handler | Mar 1997 | A |
5613957 | Py | Mar 1997 | A |
5615795 | Tipps | Apr 1997 | A |
5617976 | Gueret | Apr 1997 | A |
5641004 | Py | Jun 1997 | A |
5642838 | Stoody | Jul 1997 | A |
5664705 | Stolper | Sep 1997 | A |
5665079 | Stahl | Sep 1997 | A |
5673535 | Jagger | Oct 1997 | A |
5676267 | Slat et al. | Oct 1997 | A |
5685869 | Py | Nov 1997 | A |
5687882 | Mueller | Nov 1997 | A |
5697532 | Wilde et al. | Dec 1997 | A |
5702019 | Grimard | Dec 1997 | A |
5746728 | Py | May 1998 | A |
5772079 | Gueret | Jun 1998 | A |
5780130 | Hansen et al. | Jul 1998 | A |
5803311 | Fuchs | Sep 1998 | A |
5804236 | Frisk | Sep 1998 | A |
5816772 | Py | Oct 1998 | A |
5836484 | Gerber | Nov 1998 | A |
5842321 | Jones | Dec 1998 | A |
5857595 | Nilson | Jan 1999 | A |
5875931 | Py | Mar 1999 | A |
5909032 | Wakalopulos | Jun 1999 | A |
5931386 | Jouillat | Aug 1999 | A |
5934509 | Niss | Aug 1999 | A |
5944702 | Py | Aug 1999 | A |
5971181 | Niedospial, Jr. et al. | Oct 1999 | A |
5971224 | Garibaldi | Oct 1999 | A |
RE36410 | Meshberg | Nov 1999 | E |
5996845 | Chen | Dec 1999 | A |
6003733 | Wheeler | Dec 1999 | A |
6021824 | Larsen et al. | Feb 2000 | A |
6024252 | Clyde | Feb 2000 | A |
6033384 | Py | Mar 2000 | A |
6050435 | Bush et al. | Apr 2000 | A |
6062430 | Fuchs | May 2000 | A |
6068150 | Mitchell et al. | May 2000 | A |
6092695 | Loeffler | Jul 2000 | A |
6140657 | Wakalopulos et al. | Oct 2000 | A |
6145688 | Smith | Nov 2000 | A |
6168037 | Grimard | Jan 2001 | B1 |
6170715 | Evans | Jan 2001 | B1 |
6182698 | Barak | Feb 2001 | B1 |
6189739 | Von Schuckmann | Feb 2001 | B1 |
6199350 | Brechel et al. | Mar 2001 | B1 |
6216916 | Maddox et al. | Apr 2001 | B1 |
6254579 | Cogger et al. | Jul 2001 | B1 |
6308494 | Yuyama et al. | Oct 2001 | B1 |
RE37471 | Jagger | Dec 2001 | E |
6325253 | Robinson | Dec 2001 | B1 |
6343711 | Coughlin | Feb 2002 | B1 |
6343713 | Abplanalp | Feb 2002 | B1 |
6364864 | Mohiuddin et al. | Apr 2002 | B1 |
6382441 | Carano | May 2002 | B1 |
6385943 | Yuyama et al. | May 2002 | B2 |
6386395 | Lunghetti | May 2002 | B1 |
6419124 | Hennemann et al. | Jul 2002 | B1 |
6423040 | Benktzon et al. | Jul 2002 | B1 |
6450994 | Boyles et al. | Sep 2002 | B1 |
6455093 | Furrer et al. | Sep 2002 | B1 |
6471095 | Cann | Oct 2002 | B1 |
6478196 | Fuchs | Nov 2002 | B2 |
6491189 | Friedman | Dec 2002 | B2 |
6505622 | Py | Jan 2003 | B2 |
6506183 | Cogger | Jan 2003 | B2 |
6524287 | Cogger | Feb 2003 | B1 |
6547108 | Johanson | Apr 2003 | B2 |
6561383 | Reddy et al. | May 2003 | B1 |
6592918 | Kaeser | Jul 2003 | B2 |
6592922 | Furrer et al. | Jul 2003 | B2 |
6604561 | Py | Aug 2003 | B2 |
6610036 | Branch et al. | Aug 2003 | B2 |
6662977 | Gerber et al. | Dec 2003 | B2 |
6684916 | Py | Feb 2004 | B2 |
6695173 | Fontana | Feb 2004 | B1 |
6698628 | Mascitelli | Mar 2004 | B2 |
6742680 | Friedman | Jun 2004 | B2 |
6755327 | Hazard et al. | Jun 2004 | B1 |
D493366 | Rackwtiz | Jul 2004 | S |
6761286 | Py et al. | Jul 2004 | B2 |
6769627 | Carhuff et al. | Aug 2004 | B2 |
6802436 | Drennow et al. | Oct 2004 | B2 |
6814265 | Clifford et al. | Nov 2004 | B2 |
6883222 | Landau | Apr 2005 | B2 |
6892906 | Py et al. | May 2005 | B2 |
6957752 | Py et al. | Oct 2005 | B2 |
6962275 | deCler et al. | Nov 2005 | B2 |
6971553 | Brenner et al. | Dec 2005 | B2 |
6997219 | Py et al. | Feb 2006 | B2 |
7000806 | Py | Feb 2006 | B2 |
7000960 | Py | Feb 2006 | B2 |
7011233 | Drennow | Mar 2006 | B2 |
7032631 | Py | Apr 2006 | B2 |
7114635 | Yamada | Oct 2006 | B2 |
7278553 | Py | Oct 2007 | B2 |
7290573 | Py et al. | Nov 2007 | B2 |
7322491 | Py et al. | Jan 2008 | B2 |
7328729 | Py et al. | Feb 2008 | B2 |
7357335 | Laidler et al. | Apr 2008 | B2 |
7513395 | Labinski et al. | Apr 2009 | B2 |
7678089 | Py et al. | Mar 2010 | B2 |
7743948 | Drennow | Jun 2010 | B2 |
7789269 | Pritchard | Sep 2010 | B2 |
7806301 | Ciavarella et al. | Oct 2010 | B1 |
7810529 | Py | Oct 2010 | B2 |
7810677 | Py et al. | Oct 2010 | B2 |
7861750 | Py et al. | Jan 2011 | B2 |
7954521 | Py | Jun 2011 | B2 |
7966746 | Py | Jun 2011 | B2 |
7967034 | Py | Jun 2011 | B2 |
7980276 | Py | Jul 2011 | B2 |
8007193 | Py et al. | Aug 2011 | B2 |
8104644 | Py et al. | Jan 2012 | B2 |
8132600 | Py | Mar 2012 | B2 |
8240521 | Py | Aug 2012 | B2 |
8347923 | Py | Jan 2013 | B2 |
8408426 | Bakhos | Apr 2013 | B2 |
9022079 | Py | May 2015 | B2 |
20010027827 | Jeannin et al. | Oct 2001 | A1 |
20010041872 | Paul, Jr. | Nov 2001 | A1 |
20020006353 | Bilstad et al. | Jan 2002 | A1 |
20020010995 | Thibault et al. | Jan 2002 | A1 |
20020018731 | Bilstad et al. | Feb 2002 | A1 |
20020029022 | Naritomi et al. | Mar 2002 | A1 |
20020050301 | Jeannin et al. | May 2002 | A1 |
20020071708 | Fontanet et al. | Jun 2002 | A1 |
20020074362 | Py et al. | Jun 2002 | A1 |
20020121527 | Good | Sep 2002 | A1 |
20020124907 | Crossdale et al. | Sep 2002 | A1 |
20020131902 | Levy | Sep 2002 | A1 |
20020172615 | Woodworth et al. | Nov 2002 | A1 |
20030012858 | Furrer et al. | Jan 2003 | A1 |
20030082070 | Liberto et al. | May 2003 | A1 |
20030089743 | Py | May 2003 | A1 |
20030156973 | Bilstad et al. | Aug 2003 | A1 |
20040011820 | Abergel et al. | Jan 2004 | A1 |
20040112925 | Py et al. | Jun 2004 | A1 |
20040118291 | Carhuff et al. | Jun 2004 | A1 |
20040194811 | Carhuff et al. | Oct 2004 | A1 |
20050029307 | Py et al. | Feb 2005 | A1 |
20050072480 | Brandes | Apr 2005 | A1 |
20050089358 | Py et al. | Apr 2005 | A1 |
20050165368 | Py et al. | Jul 2005 | A1 |
20050260090 | Stark et al. | Nov 2005 | A1 |
20060169722 | Py et al. | Aug 2006 | A1 |
20060186139 | Laidler et al. | Aug 2006 | A1 |
20090224002 | Bakhos | Sep 2009 | A1 |
20110297677 | Py et al. | Dec 2011 | A1 |
20120111894 | Bakhos | May 2012 | A1 |
20130214009 | Bakhos | Aug 2013 | A1 |
Number | Date | Country |
---|---|---|
1123792 | May 1982 | CA |
2436454 | Jun 2001 | CN |
0172711 | Feb 1986 | EP |
0616141 | Sep 1994 | EP |
0649795 | Apr 1995 | EP |
0733559 | Sep 1996 | EP |
0743263 | Nov 1996 | EP |
0 802 827 | Aug 1998 | EP |
1546021 | Feb 2004 | EP |
2509689 | Jul 1981 | FR |
2709733 | Mar 1995 | FR |
500534 | Feb 1939 | GB |
984149 | Feb 1965 | GB |
2091229 | Jul 1982 | GB |
2364700 | Feb 2002 | GB |
52-91345 | Jul 1977 | JP |
S59-10986 | Apr 1984 | JP |
63-156978 | Oct 1988 | JP |
H2-21078 | Jun 1990 | JP |
2-97427 | Aug 1990 | JP |
2-111636 | Sep 1990 | JP |
06-239379 | Aug 1994 | JP |
07-125799 | May 1995 | JP |
10-156269 | Jun 1998 | JP |
11-268778 | Oct 1999 | JP |
2002-347812 | Dec 2002 | JP |
05-016950 | Jan 2003 | JP |
2005-535530 | Nov 2005 | JP |
WO8503062 | Jul 1985 | WO |
WO 9316955 | Sep 1993 | WO |
WO 9621512 | Jul 1996 | WO |
WO 9932185 | Jan 1999 | WO |
WO 9941158 | Aug 1999 | WO |
WO 0029192 | May 2000 | WO |
WO 0240122 | May 2002 | WO |
WO 03033363 | Apr 2003 | WO |
2004039690 | May 2004 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/US/2013/36296 issued Aug. 30, 2013. 12 pages. |
International Search Report for International Application No. PCT/US2003/33503 issued Dec. 1, 2004. 1 page. |
Number | Date | Country | |
---|---|---|---|
20130175299 A1 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
60242595 | Oct 2000 | US | |
60242974 | Oct 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11351716 | Feb 2006 | US |
Child | 13572145 | US | |
Parent | 10890465 | Jul 2004 | US |
Child | 11351716 | US | |
Parent | 10001745 | Oct 2001 | US |
Child | 10890465 | US |